SNS Insider Black Friday Offer
Medical Collagen Market

Medical Collagen Market Size, Share & Segment by Source (Porcine, Bovine, Others), By Product (Hydrolysed Collagen, Gelatine, Native Collagen, Others), By Application (Wound Care, Cartilage Repair, Bone Grafts, Tissue Scaffolds, Diagnostics, Vascular Grafts, Haemostats, Other), and by Regions | Global Market Forecast 2022-2028

Report Id: SNS/HC/1777 | June 2022 | Region: Global | 125 Pages

Report Scope & Overview:

The Medical Collagen Market Size was valued at USD 6316 million in 2021, and is expected to reach USD 9752 million by 2028, and grow at a CAGR of 6.4% over the forecast period 2022-2028.

Medical Collagen is an important protein in the human body's connective tissues. Medical collagen offers a wide range of applications in surgery and illness therapy. It's utilised for bone restoration, dental surgery, and bovine treatment in aesthetic surgery. Medical collagen is widely used in the orthopedic business because it strengthens bones and prevents them from breaking down. Medical Collagen is employed for tissue regeneration since it contains cell deposition and hydrophilicity qualities.

Medical Collagen Market

Collagen is essential for healthy joints because it gives structure to the skin, joints, and bones, as well as aiding in blood clotting. It is one of the most important components of human skin, accounting for over 75percent of the skin's support structure. Collagen is commonly utilised in cosmetic surgery and as a burn victim's wound healing treatment. They're also commonly employed for bone rebuilding and a number of dental, orthopedic, and surgical procedures. In the approaching years, the pharmaceutical and health-care industries are projected to provide attractive prospects for collagen manufacturers.

It is used to treat wounds because of its great antibacterial qualities and sterility. Collagen is used by medical research organisations to examine the behavior of cells and their interactions with the other cells in the human body. Collagen is utilized to support cell proliferation in lattice structures and cell-binding regions in cell cultures. The use of regenerative operations to treat skin malignancies, burn injuries, and birth deformities is projected to propel the industry forward. Medical collagen is also commonly utilised in the treatment of cardiovascular problems.

MARKET DYNAMICS 

DRIVERS

  • Collagen's Use in the Medical Industry is Increasing

  • Approvals from the FDA are increasing, and new products are being introduced.

RESTRAINTS

  • Treatment's exorbitant expenses

  • Low reimbursements stifle expansion.

OPPORTUNITIES

  • Emerging economies provide enormous prospects.

CHALLENGES

  • Processing technology that is insufficient

By Product:

Gelatin, hydrolyzed collagen, native collagen, and others make up the medical collagen market. In 2021, the gelatin segment had the biggest market share, and it is expected to grow at the fastest rate over the forecast period.

By Application:

Haemostats, vascular grafts, tissue scaffolds, cartilage repair, wound care, bone grafts, diagnostics, and other are the different segments of the medical collagen market. In 2021, the wound care sector had the biggest share, and the market for bone grafts is expected to grow at the fastest rate over the forecast period.

By Source:

Divided into bovine, porcine, and other categories. In 2021, the bovine segment accounted for the greatest proportion of the market, and it is expected to grow at the fastest rate over the forecast period.

COMPETITIVE LANDSCAPE

Some of the major key players are as follows: Collplant Biotechnologies Ltd, Collagen Solutions Plc, Croda Interntional PLC., Collagen Matrix Inc., DSM, Encoll, Gelita AG, Integra Lifesciences Corporation, Innocoll, Symatese, and other players.

MARKET SEGMENTATION:

By Source

  • Porcine

  • Bovine

  • Others

By Product

  • Hydrolysed Collagen

  • Gelatine

  • Native Collagen

  • Others

By Application

  • Wound Care

  • Cartilage Repair

  • Bone Grafts

  • Tissue Scaffolds

  • Diagnostics

  • Vascular Grafts

  • Haemostats

  • Other

Medical Collagen Market

REGIONAL ANALYSIS

The world market for medical collagen was controlled by North America. Medical collagen is used in reconstructive surgeries, tissue engineering, bone grafts, wound and burn damage treatments, and other applications, which is driving the market expansion in the region. In addition, the market's expansion is aided by frequent product introductions. Collagen Matrix, Inc.'s revolutionary brand of Mineral Collagen Composite Bioactive Moldable Bone Graft Matrix got FDA approval in April 2019. The OssiMend Bioactive Moldable Bone Graft Matrix is a unique blend of organic carbonate apatite bone mineral, 45S5 bioactive glass, and highly purified Type I collagen that can be moulded into putty to fill uneven defect locations. The new matrix is part of the company's extensive line of collagen and mineral-based medical devices that can be implanted.

REGIONAL COVERAGE:

  • North America

    • USA

    • Canada

    • Mexico

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • The Netherlands

    • Rest of Europe

  • Asia-Pacific

    • Japan

    • south Korea

    • China

    • India

    • Australia

    • Rest of Asia-Pacific

  • The Middle East & Africa

    • Israel

    • UAE

    • South Africa

    • Rest of Middle East & Africa

  • Latin America

    • Brazil

    • Argentina

    • Rest of Latin America

Medical Collagen Market Repost Scope:
Report Attributes Details
Market Size in 2021 US$ 6316 Million
Market Size by 2028 US$ 9752 Million
CAGR CAGR of 6.4% From 2022 to 2028
Base Year 2021
Forecast Period 2022-2028
Historical Data 2017-2020
Report Scope & Coverage Market Size, Segments Analysis, Competitive  Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook
Key Segments • By Source (Porcine, Bovine, Others)
• By Product (Hydrolysed Collagen, Gelatine, Native Collagen, Others)
• By Application (Wound Care, Cartilage Repair, Bone Grafts, Tissue Scaffolds, Diagnostics, Vascular Grafts, Haemostats, Other)
Regional Analysis/Coverage North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
Company Profiles Collplant Biotechnologies Ltd, Collagen Solutions Plc, Croda Interntional PLC., Collagen Matrix Inc., DSM, Encoll, Gelita AG, Integra Lifesciences Corporation, Innocoll, Symatese, and other players.
DRIVERS • Collagen's Use in the Medical Industry is Increasing
• Approvals from the FDA are increasing, and new products are being introduced.
RESTRAINTS • Treatment's exorbitant expenses
• Low reimbursements stifle expansion.


Frequently Asked Questions (FAQ) :

Low reimbursements and stifle expansion are the main restraints of the Medical Collagen market.

Collagen's Use in the Medical Industry is Increasing, Approvals from the FDA are increasing, and new products are the drivers of medical collagen market.

Market for medical collagen was controlled by North America.

The gelatin segment had the biggest market share, and it is expected to grow at the fastest rate over the forecast period.

Medical Collagen Market Size was valued at USD 6316 million in 2021.


Table of Contents

 

1. Introduction

1.1 Market Definition

1.2 Scope

1.3 Research Assumptions

 

2. Research Methodology

 

3. Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

 

4. Impact Analysis

4.1 COVID 19 Impact Analysis

4.2 Impact of Ukraine ware

 

5. Value Chain Analysis

 

6. Porter’s 5 forces model

 

7.  PEST Analysis

  

8. Medical Collagen Market Segmentation, By Source

8.1 Porcine

8.2 Bovine

8.3 Others

 

9. Medical Collagen Market Segmentation, By Product

9.1 Hydrolysed Collagen

9.2 Gelatine

9.3 Native Collagen

9.4 Others

 

10. Medical Collagen Market Segmentation, By Application

10.1 Wound Care

10.2 Cartilage Repair

10.3 Bone Grafts

10.4 Tissue Scaffolds

10.5 Diagnostics

10.6 Vascular Grafts

10.7Haemostats

10.8 Other

 

11. Regional Analysis

11.1 Introduction

11.2 North America

11.2.1 USA

11.2.2 Canada

11.2.3 Mexico

11.3 Europe

11.3.1 Germany

11.3.2 UK

11.3.3 France

11.3.4 Italy

11.3.5 Spain

11.3.6 The Netherlands

11.3.7 Rest of Europe

11.4 Asia-Pacific

11.4.1 Japan

11.4.2 South Korea

11.4.3 China

11.4.4 India

11.4.5 Australia

11.4.6 Rest of Asia-Pacific

11.5 The Middle East & Africa

11.5.1 Israel

11.5.2 UAE

11.5.3 South Africa

11.5.4 Rest

11.6 Latin America

11.6.1 Brazil

11.6.2 Argentina

11.6.3 Rest of Latin America

 

12 Company Profiles

12.1 Collplant Biotechnologies Ltd

            12.1.1 Financial

12.1.2 Products/ Services Offered

12.1.3 SWOT Analysis

12.1.4 The SNS view

12.2 Collagen Solutions Plc

12.3 Croda Interntional PLC.

12.4 Collagen Matrix Inc.

12.5 DSM

12.6 Encoll

12.7 Gelita AG

12.8 Integra Lifesciences Corporation

12.9 Innocoll

12.10 Symatese.

 

13 Competitive Landscape

13.1 Competitive Benchmark

13.2 Market Share analysis

13.3 Recent Developments

 

14 Conclusion

 

An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.

Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.

 

The 5 steps process:

Step 1: Secondary Research:

Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.

Secondary Research

Step 2: Primary Research

When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data.  This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.

We at SNS Insider have divided Primary Research into 2 parts.

Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.

This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.

Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.

Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.

Step 3: Data Bank Validation

Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.

Step 4: QA/QC Process

After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.

Step 5: Final QC/QA Process:

This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.